Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
3.275
+0.075 (2.34%)
Jun 25, 2026, 10:33 AM EDT - Market open
Accendra Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,716 | 2,762 | 2,680 | 2,553 | 9,955 | 9,785 | |
Revenue Growth (YoY) | -0.01% | 3.06% | 5.00% | -74.36% | 1.74% | 15.39% |
Cost of Revenue | 1,468 | 1,473 | 1,400 | 1,336 | 8,129 | 8,272 |
Gross Profit | 1,248 | 1,289 | 1,280 | 1,217 | 1,826 | 1,513 |
Selling, General & Admin | 1,060 | 1,068 | 1,082 | 1,002 | 1,555 | 1,077 |
Other Operating Expenses | 162.88 | 194.28 | 415.77 | 82.13 | 128.62 | 67.69 |
Total Operating Expenses | 1,223 | 1,262 | 1,498 | 1,084 | 1,683 | 1,145 |
Operating Income | -39.71 | 27.46 | -217.73 | 133.23 | 142.91 | 368.47 |
Interest Expense | -115.32 | -107.18 | -107.57 | -116.77 | -128.89 | -48.09 |
Other Non-Operating Income (Expense) | -22.28 | -22.23 | -4.59 | -1.2 | -3.13 | -3.2 |
Total Non-Operating Income (Expense) | -137.6 | -129.41 | -112.16 | -117.97 | -132.02 | -51.29 |
Pretax Income | -88.58 | -101.95 | -329.89 | 15.27 | 10.89 | 276.75 |
Provision for Income Taxes | -10.91 | 0.73 | 20.85 | 6.36 | -11.5 | 55.17 |
Net Income | -105.34 | -102.68 | -350.74 | 8.91 | 22.39 | 221.59 |
Earnings From Discontinued Operations | -1,024 | -997.96 | -11.95 | -50.21 | - | - |
Net Income to Common | -1,019 | -1,101 | -362.69 | -41.3 | 22.39 | 221.59 |
Net Income Growth | - | - | - | - | -89.90% | 641.82% |
Shares Outstanding (Basic) | 77 | 77 | 77 | 76 | 74 | 73 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 77 | 76 | 75 |
Shares Change (YoY) | -0.74% | 0.20% | -0.81% | 1.51% | 0.97% | 18.85% |
EPS (Basic) | -14.05 | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 |
EPS (Diluted) | -14.05 | -14.31 | -4.73 | -0.53 | 0.29 | 2.94 |
EPS Growth | - | - | - | - | -90.14% | 525.53% |
Free Cash Flow | -293.71 | -292.75 | -8.79 | 568.34 | 166.92 | 83.19 |
Free Cash Flow Growth | - | - | - | 240.49% | 100.64% | -71.19% |
Free Cash Flow Per Share | -3.82 | -3.81 | -0.11 | 7.35 | 2.19 | 1.10 |
Dividends Per Share | - | - | - | - | - | 0.010 |
Gross Margin | 45.95% | 46.68% | 47.77% | 47.68% | 18.35% | 15.46% |
Operating Margin | -1.46% | 0.99% | -8.12% | 5.22% | 1.44% | 3.77% |
Profit Margin | -3.88% | -3.72% | -13.09% | 0.35% | 0.22% | 2.26% |
FCF Margin | -10.81% | -10.60% | -0.33% | 22.27% | 1.68% | 0.85% |
EBITDA | 175.4 | 241.98 | -36.45 | 343.6 | 371.58 | 459.09 |
EBITDA Margin | 6.46% | 8.76% | -1.36% | 13.46% | 3.73% | 4.69% |
EBIT | -39.71 | 27.46 | -217.73 | 133.23 | 142.91 | 368.47 |
EBIT Margin | -1.46% | 0.99% | -8.12% | 5.22% | 1.44% | 3.77% |
Effective Tax Rate | 12.31% | -0.72% | -6.32% | 41.66% | -105.57% | 19.93% |